Mativ Holdings, Inc.
Business
Mativ Holdings, Inc. is a global specialty materials manufacturer that engineers solutions to connect, protect, and purify across diverse end markets. It produces highly engineered media and converted products including nonwovens, films, nets, specialty papers, release liners, tapes, adhesive systems, and filtration components. The company operates through two reportable segments: Filtration & Advanced Materials (filtration media, advanced films, mesh and related components) and Sustainable & Adhesive Solutions (tapes, labels, liners, paper, packaging and healthcare products). Mativ manufactures on multiple continents and sells globally through direct channels and distributors, delivering by truck, rail and ocean transport.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 1,987 | 1,981 | 2,026 | 1,637 | 931 | |
| Cost of products sold | 1,624 | 1,617 | 1,670 | 1,331 | 748 | |
| Gross profit | 363 | 364 | 356 | 306 | 183 | |
| Selling and general expense | 229 | 234 | 264 | 255 | — | |
| Research and development expense | 24 | 23 | 21 | 19 | 12 | |
| Intangible asset amortization expense | 63 | 63 | 61 | 53 | — | |
| Total nonmanufacturing expenses | 316 | 320 | 346 | 327 | 198 | |
| Goodwill impairment expense | 412 | 0 | 401 | 0 | 0 | |
| Restructuring and other impairment expense | 20 | 38 | 23 | 19 | 2 | |
| Operating profit (loss) | −384 | 6 | −414 | −40 | −16 | |
| Interest expense | 71 | 75 | 62 | 57 | — | |
| Loss on debt extinguishment | 0 | 7 | 0 | 0 | — | |
| Other expense, net | −8 | −3 | −5 | 1 | — | |
| Loss from continuing operations before income taxes | −463 | −79 | −481 | −97 | −27 | |
| Income tax expense (benefit) | −126 | −30 | 27 | −28 | 28 | |
| Net loss from continuing operations | −337 | −49 | −508 | −69 | 2 | |
| Income from discontinued operations, net of tax | 0 | 0 | 198 | 62 | 87 | |
| Net loss | −337 | −49 | −310 | −7 | 89 | |
| Loss per share from continuing operations (in dollars per share) | −6.19 | −0.9 | −9.33 | −1.64 | 0.02 | |
| Income per share from discontinued operations (in dollars per share) | 0 | 0 | 3.64 | 1.46 | 2.81 | |
| Basic (in dollars per share) | −6.19 | −0.9 | −5.69 | −0.18 | 2.83 | |
| Loss per share from continuing operations (in dollars per share) | −6.19 | −0.9 | −9.33 | −1.64 | 0.02 | |
| Income per share from discontinued operations (in dollars per share) | 0 | 0 | 3.64 | 1.46 | 2.78 | |
| Diluted (in dollars per share) | −6.19 | −0.9 | −5.69 | −0.18 | 2.8 | |
| Basic (in shares) | 55 | 54 | 55 | 42 | 31 | |
| Diluted (in shares) | 55 | 54 | 55 | 42 | 31 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 84 | 94 | 120 | 101 | 71 | |
| Restricted Cash | 6 | 0 | — | — | — | |
| Accounts receivable, net | 181 | 162 | 177 | 178 | 238 | |
| Inventories, net | 329 | 355 | 353 | 415 | 260 | |
| Income taxes receivable | 18 | 21 | 31 | 19 | 10 | |
| Other current assets | 21 | 26 | 32 | 28 | 12 | |
| Total current assets | 639 | 658 | 713 | 975 | 595 | |
| Property, plant and equipment, net | 609 | 620 | 673 | 692 | 462 | |
| Finance lease right-of-use assets | 16 | 16 | 18 | 17 | 2 | |
| Operating lease right-of-use assets | 48 | 46 | 46 | 31 | 25 | |
| Deferred income tax assets | 104 | 8 | 6 | 34 | 34 | |
| Goodwill | 58 | 466 | 474 | 844 | 645 | |
| Intangible assets, net | 514 | 553 | 631 | 710 | 514 | |
| Other assets | 64 | 80 | 82 | 110 | 76 | |
| Total assets | 2,052 | 2,448 | 2,642 | 3,669 | 2,420 | |
| Current debt | 3 | 3 | 3 | 34 | 3 | |
| Finance lease liabilities | 2 | 2 | 1 | 900,000 | 500,000 | |
| Operating lease liabilities | 9 | 10 | 10 | 9 | 7 | |
| Accounts payable | 161 | 152 | 139 | 181 | 116 | |
| Income taxes payable | 2 | 8 | 14 | 10 | 3 | |
| Accrued expenses and other current liabilities | 109 | 101 | 114 | 129 | 102 | |
| Total current liabilities | 285 | 275 | 281 | 466 | 231 | |
| Long-term debt | 1,015 | 1,087 | 1,102 | 1,656 | 1,265 | |
| Finance lease liabilities, noncurrent | 16 | 16 | 18 | 18 | 2 | |
| Operating lease liabilities, noncurrent | 39 | 36 | 35 | 25 | 19 | |
| Pension and other postretirement benefits | 54 | 54 | 62 | 60 | 39 | |
| Deferred income tax liabilities | 75 | 101 | 142 | 152 | 95 | |
| Other liabilities | 69 | 20 | 44 | 32 | 71 | |
| Total liabilities | 1,553 | 1,589 | 1,693 | 2,490 | 1,738 | |
| Preferred stock, $0.10 par value per share; 10,000,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.10 par value per share; 100,000,000 shares authorized; 54,681,114 and 54,335,830 shares issued and outstanding at December 31, 2025 and 2024, respectively | 6 | 5 | 5 | 6 | 3 | |
| Additional paid-in-capital | 685 | 676 | 670 | 659 | 102 | |
| Retained earnings (accumulated deficit) | −196 | 164 | 235 | 611 | 696 | |
| Accumulated other comprehensive income, net of tax | 4 | 13 | 39 | −95 | −119 | |
| Total stockholders' equity | 499 | 859 | 949 | 1,179 | 682 | |
| Total liabilities and stockholders' equity | 2,052 | 2,448 | 2,642 | 3,669 | 2,420 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 141 | 144 | 148 | 110 | 67 | |
| Amortization of deferred issuance costs | 8 | 8 | 8 | 6 | 4 | |
| Other impairments | 12 | 16 | 18 | 14 | 2 | |
| Deferred income tax | −130 | −34 | 24 | −29 | −29 | |
| Pension and other postretirement benefits | −3 | −6 | −8 | −7 | −1 | |
| Stock-based compensation | 11 | 11 | 11 | 20 | 9 | |
| Loss (gain) on sale of assets | −300,000 | 6 | 0 | −3 | — | |
| Loss (gain) on foreign currency transactions | 7 | −1 | 5 | −8 | −4 | |
| Other non-cash items | 10 | −5 | −13 | 2 | −7 | |
| Cash received from settlement of interest swap agreements | 0 | 0 | 16 | 24 | 0 | |
| Other operating | −4 | −2 | −5 | 0 | 0 | |
| Accounts receivable | −15 | 6 | 2 | 157 | 3 | |
| Inventories | 19 | −26 | 52 | −63 | −16 | |
| Prepaid expenses | 100,000 | 2 | −200,000 | −200,000 | 900,000 | |
| Accounts payable and other current liabilities | 8 | 21 | −64 | −15 | −3 | |
| Accrued income taxes | −5 | −3 | −9 | −16 | 1 | |
| Net changes in operating working capital | 8 | 100,000 | −20 | 63 | −15 | |
| Continuing operations | 134 | 95 | 77 | 125 | −8 | |
| Discontinued operations | 0 | 0 | 30 | 78 | 66 | |
| Net cash provided by operations | 134 | 95 | 107 | 202 | 58 | |
| Capital spending | −40 | −55 | −66 | −46 | −19 | |
| Proceeds from sale of assets | 3 | 6 | 0 | 8 | 35 | |
| Cash received from (paid on) settlement of cross-currency swap contracts | 3 | −2 | 0 | 36 | — | |
| Other investing | −3 | 6 | 5 | −2 | −800,000 | |
| Continuing operations | −37 | −45 | −61 | −469 | −618 | |
| Discontinued operations | 0 | −12 | 609 | −12 | −18 | |
| Net cash provided by (used in) investing | −37 | −57 | 547 | −481 | −636 | |
| Cash dividends paid | −22 | −22 | −55 | −72 | −55 | |
| Proceeds from long-term debt | 82 | 531 | 241 | 775 | 744 | |
| Payments on long-term debt | −162 | −555 | −835 | −341 | −54 | |
| Payments for debt issuance costs | 0 | −8 | −2 | −22 | −15 | |
| Payments on financing lease obligations | −3 | −2 | −1 | −600,000 | −15 | |
| Purchases of common stock and shares withheld for employee taxes | −1 | −800,000 | −11 | −7 | — | |
| Continuing operations | −107 | −56 | −662 | 333 | 601 | |
| Discontinued operations | 0 | 0 | −900,000 | −1 | −700,000 | |
| Net cash used in financing | −107 | −56 | −663 | 332 | 600 | |
| Effect of exchange rate changes on Cash and cash equivalents and Restricted cash | 5 | −8 | 5 | −3 | −2 | |
| Decrease in Cash and cash equivalents and Restricted cash | −5 | −26 | −4 | 50 | 20 | |
| Cash paid for interest, net | 83 | 91 | 121 | 85 | 47 | |
| Cash paid for taxes, net | 12 | 15 | 38 | 26 | 22 | |
| Capital spending in accounts payable and accrued liabilities | 5 | 7 | 10 | 15 | 6 |